| Title |
Use of Combination Chemotherapy for Treatment of Granulomatous and Lymphocytic Interstitial Lung Disease (GLILD) in Patients with Common Variable Immunodeficiency (CVID)
|
|---|---|
| Published in |
Journal of Clinical Immunology, August 2012
|
| DOI | 10.1007/s10875-012-9755-3 |
| Pubmed ID | |
| Authors |
Nicole M. Chase, James W. Verbsky, Mary K. Hintermeyer, Jill K. Waukau, Aoy Tomita-Mitchell, James T. Casper, Sumit Singh, Kaushik S. Shahir, William B. Tisol, Melodee L. Nugent, R. Nagarjun Rao, A. Craig Mackinnon, Lawrence R. Goodman, Pippa M. Simpson, John M. Routes |
| Abstract |
A subset of patients with common variable immunodeficiency (CVID) develops granulomatous and lymphocytic interstitial lung disease (GLILD), a restrictive lung disease associated with early mortality. The optimal therapy for GLILD is unknown. This study was undertaken to see if rituximab and azathioprine (combination chemotherapy) would improve pulmonary function and/or radiographic abnormalities in patients with CVID and GLILD. |
X Demographics
The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 50% |
| Brazil | 1 | 25% |
| Canada | 1 | 25% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 50% |
| Science communicators (journalists, bloggers, editors) | 1 | 25% |
| Scientists | 1 | 25% |
Mendeley readers
The data shown below were compiled from readership statistics for 109 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | <1% |
| Denmark | 1 | <1% |
| Unknown | 107 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 15 | 14% |
| Researcher | 14 | 13% |
| Student > Bachelor | 11 | 10% |
| Student > Ph. D. Student | 9 | 8% |
| Student > Postgraduate | 9 | 8% |
| Other | 28 | 26% |
| Unknown | 23 | 21% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 58 | 53% |
| Immunology and Microbiology | 8 | 7% |
| Agricultural and Biological Sciences | 3 | 3% |
| Nursing and Health Professions | 2 | 2% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 2% |
| Other | 9 | 8% |
| Unknown | 27 | 25% |
Attention Score in Context
This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 January 2019.
All research outputs
#4,607,819
of 22,679,690 outputs
Outputs from Journal of Clinical Immunology
#272
of 1,556 outputs
Outputs of similar age
#33,485
of 170,150 outputs
Outputs of similar age from Journal of Clinical Immunology
#6
of 31 outputs
Altmetric has tracked 22,679,690 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,556 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.2. This one has done well, scoring higher than 82% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 170,150 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 80% of its contemporaries.
We're also able to compare this research output to 31 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 80% of its contemporaries.